Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS

Bioanalysis

Volumn 6, Issue 11, 2014, Pages 1471-1485

  Gandhi, Adarsh S ^a   Zhu, Mingshe ^b   Pang, Shaokun ^c   Wohlfarth, Ariane ^a   Scheidweiler, Karl B ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c MDS SCIEX   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 METHOXYPHENYL) 1 (1 PENTYL INDOL 3 YL)METHANONE; CANNABINOID RECEPTOR AGONIST; UNCLASSIFIED DRUG; CANNABINOID; DESIGNER DRUG;

ARTICLE; CARBOXYLATION; CONTROLLED STUDY; DEALKYLATION; DEMETHYLATION; GLUCURONIDATION; HUMAN; HUMAN CELL; HYDROXYLATION; LIVER METABOLISM; METABOLITE; PROTON TRANSPORT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SULFATION; TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS; LIVER CELL; MASS SPECTROMETRY; METABOLISM; PROCEDURES;

CANNABINOIDS; DESIGNER DRUGS; HEPATOCYTES; HUMANS; MASS SPECTROMETRY;

EID: 84904624043     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.13     Document Type: Article

References (39)

1. Di Marzo V, Petrocellis LD. Plant, synthetic, and endogenous cannabinoids in medicine. Annu. Rev. Med. 57, 553-574 (2006).
2. Wiley JL, Marusich JA, Huffman JW, Balster RL, Thomas BF. Hijacking of basic research:the case of synthetic cannabinoids. Methods Rep RTI Press 2011, 17971 (2011).
3. Dresen S, Ferreiros N, Putz M, Westphal F, Zimmermann R, Auwarter V. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J. Mass Spectrom. 45(10), 1186-1194 (2010).
4. Hutter M, Kneisel S, Auwarter V, Neukamm MA. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 903, 95-101 (2012).
5. Hutter M, Broecker S, Kneisel S, Auwarter V. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques. J. Mass Spectrom. 47(1), 54-65 (2012).
6. Yanes EG, Lovett DP. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 909, 42-50 (2012).
7. Shanks KG, Dahn T, Terrell AR. Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework. J. Anal. Toxicol. 36(3), 145-152 (2012).
8. Kneisel S, Speck M, Moosmann B, Corneillie TM, Butlin NG, Auwarter V. LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows. Anal. Bioanal. Chem. 405(14), 4691-4706 (2013).
9. Wohlfarth A, Scheidweiler KB, Chen X, Liu HF, Huestis MA. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Anal. Chem. 85(7), 3730-3738 (2013).
10. de Jager AD, Warner JV, Henman M, Ferguson W, Hall A. LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine-an Australian perspective. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 897, 22-31 (2012).
11. Kneisel S, Auwarter V. Analysis of 30 synthetic cannabinoids in serum by liquid chromatographyelectrospray ionization tandem mass spectrometry after liquid-liquid extraction. J. Mass Spectrom. 47(7), 825-835 (2012).
12. Kavanagh P, Grigoryev A, Melnik A, Simonov A. The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry. J. Anal. Toxicol. 36(5), 303-311 (2012).
13. Grigoryev A, Melnik A, Savchuk S, Simonov A, Rozhanets V. Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(25), 2519-2526 (2011).
14. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Test Anal. doi:10.1002/dta.1418 (2012) (Epub ahead of print).
15. CESAR. Synthetic marijuana third most reported substance used by US high school students. CESAR FAX Report 22, 17 (2013).
16. Kim J, In S, Park Y, Park M, Kim E, Lee S. Deposition of JWH-018, JWH-073 and their metabolites in hair and effect of hair pigmentation. Anal. Bioanal. Chem. 405(30), 9769-9778 (2013).
17. Gottardo R, Sorio D, Musile G, et al. Screening for synthetic cannabinoids in hair by using LC-QTOF MS:a new and powerful approach to study the penetration of these new psychoactive substances in the population. Med. Sci. Law 54(1), 22-27 ( 2014).
18. Salomone A, Gerace E, D'Urso F, Di Corcia D, Vincenti M. Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. J. Mass Spectrom. 47(5), 604-610 (2012).
19. Salomone A, Luciano C, Di Corcia D, Gerace E, Vincenti M. Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers. Drug Test. Anal. 6(1-2), 126-134 ( 2014).
20. Coulter C, Garnier M, Moore C. Synthetic cannabinoids in oral fluid. J. Anal. Toxicol. 35(7), 424-430 (2011).
21. de Castro A, Pineiro B, Lendoiro E, Cruz A, Lopez-Rivadulla M. Quantification of selected synthetic cannabinoids and Delta9- tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1295, 99-106 (2013).
22. Oiestad EL, Johansen U, Christophersen AS, Karinen R. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS. Bioanalysis 5(18), 2257-2268 (2013).
23. Rodrigues WC, Catbagan P, Rana S, Wang G, Moore C. Detection of synthetic cannabinoids in oral f luid using ELISA and LC-MS-MS. J. Anal. Toxicol. 37(8), 526-533 (2013).
24. Strano-Rossi S, Anzillotti L, Castrignano E, Romolo FS, Chiarotti M. Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, 'spice' and stimulants in oral f luid. J. Chromatogr. A 1258, 37-42 (2012).
25. Scheidweiler KB, Cone EJ, Moolchan ET, Huestis MA. Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutaneous cocaine administration. J. Pharmacol. Exp. Ther. 313(2), 909-915 (2005).
26. Aung MM, Griffin G, Huffman JW, et al. Inf luence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend. 60(2), 133-140 (2000).
27. Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science 296(5568), 678-682 (2002).
28. Rajasekaran M, Brents LK, Franks LN, Moran JH, Prather PL. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Toxicol. Appl. Pharmacol. 269(2), 100-108 (2013).
29. Brents LK, Gallus-Zawada A, Radominska-Pandya A, et al. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochem. Pharmacol. 83(7), 952-961 (2012).
30. Brents LK, Reichard EE, Zimmerman SM, Moran JH, Fantegrossi WE, Prather PL. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS ONE 6(7), e21917 (2011).
31. Chimalakonda KC, Seely KA, Bratton SM, et al. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metab. Dispos. 40(11), 2174-2184 (2012).
32. Chimalakonda KC, Bratton SM, Le VH, et al. Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDPglucuronosyltransferases. Drug Metab. Dispos. 39(10), 1967-1976 (2011).
33. Jin MJ, Lee J, In MK, Yoo HH. Characterization of in vitro metabolites of CP 47, 497, a synthetic cannabinoid, in human liver microsomes by LC-MS/MS. J. Forensic Sci. 58(1), 195-199 (2013).
34. Kim U, Jin MJ, Lee J, Han SB, In MK, Yoo HH. Tentative identification of Phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS. J. Pharm. Biomed. Anal. 64-65, 26-34 (2012).
35. Wintermeyer A, Moller I, Thevis M, et al. In vitro Phase I metabolism of the synthetic cannabimimetic JWH-018. Anal. Bioanal. Chem. 398(5), 2141-2153 (2010).
36. Logan BK, Reinhold LE, Xu A, Diamond FX. Identification of synthetic cannabinoids in herbal incense blends in the United States. J. Forensic Sci. 57(5), 1168-1180 (2012).
37. Denooz R, Vanheugen JC, Frederich M, de Tullio P, Charlier C. Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products. J. Anal. Toxicol. 37(2), 56-63 (2013).
38. Patton AL, Chimalakonda KC, Moran CL, et al. K2 toxicity:fatal case of psychiatric complications following AM2201 exposure. J. Forensic Sci. 58(6), 1676-1680 (2013).
39. Gandhi AS, Zhu M, Pang S, et al. First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. AAPS J. 15(4), 1091-1098 (2013).